Search research articles
Contact Us
Filters
Showing results (81-90 of 167) with videos related to
Page
of 17
Sort By:
Current Topics in Medicinal Chemistry
|
September 17, 2009
Behavioural sensitisation during dopamine replacement therapy in Parkinson's disease is reminiscent of the addicted brain
F Biagioni, A Pellegrini, S Ruggieri, et al.
Basic and Applied Histochemistry
|
January 1, 1987
NAD pyrophosphorylase from yeast chromatin. Purification and properties
G Magni, P Natalini, I Santarelli, et al.
Italian Journal of Neurological Sciences
|
February 1, 1986
Multicenter trial of L-Deprenyl in Parkinson disease
S Ruggieri, A Denaro, G Meco, et al.
Muscle & Nerve
|
May 19, 1998
Reciprocal inhibition in forearm muscles in patients with essential tremor
B Mercuri, A Berardelli, N Modugno, et al.
Current Medicinal Chemistry
|
April 14, 2004
Structure and function of nicotinamide mononucleotide adenylyltransferase
G Magni, A Amici, M Emanuelli, et al.
Minerva Medica
|
November 3, 1976
[Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor]
A Agnoli, M Casacchia, A Carolei, et al.
Journal of Chromatography. B, Biomedical Applications
|
February 9, 1996
Three-minute high-performance liquid chromatographic assay for NMN adenylyltransferase using a 20-mm-long reversed-phase column
M Emanuelli, N Raffaelli, A Amici, et al.
Journal of Neurology
|
May 1, 1996
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester
F Stocchi, L Barbato, L Bramante, et al.
Blood
|
August 15, 2000
Human erythrocyte pyrimidine 5-nucleotidase, PN-I, is identical to p36, a protein associated to lupus inclusion formation in response to alpha-interferon
A Amici, M Emanuelli, N Raffaelli, et al.
Clinical Neuropharmacology
|
June 1, 1997
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease
S Ruggieri, M F De Pandis, A Bonamartini, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 167) with videos related to
Sort By:
Page
of 17
Current Topics in Medicinal Chemistry
|
September 17, 2009
Behavioural sensitisation during dopamine replacement therapy in Parkinson's disease is reminiscent of the addicted brain
F Biagioni, A Pellegrini, S Ruggieri, et al.
Basic and Applied Histochemistry
|
January 1, 1987
NAD pyrophosphorylase from yeast chromatin. Purification and properties
G Magni, P Natalini, I Santarelli, et al.
Italian Journal of Neurological Sciences
|
February 1, 1986
Multicenter trial of L-Deprenyl in Parkinson disease
S Ruggieri, A Denaro, G Meco, et al.
Muscle & Nerve
|
May 19, 1998
Reciprocal inhibition in forearm muscles in patients with essential tremor
B Mercuri, A Berardelli, N Modugno, et al.
Current Medicinal Chemistry
|
April 14, 2004
Structure and function of nicotinamide mononucleotide adenylyltransferase
G Magni, A Amici, M Emanuelli, et al.
Minerva Medica
|
November 3, 1976
[Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor]
A Agnoli, M Casacchia, A Carolei, et al.
Journal of Chromatography. B, Biomedical Applications
|
February 9, 1996
Three-minute high-performance liquid chromatographic assay for NMN adenylyltransferase using a 20-mm-long reversed-phase column
M Emanuelli, N Raffaelli, A Amici, et al.
Journal of Neurology
|
May 1, 1996
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester
F Stocchi, L Barbato, L Bramante, et al.
Blood
|
August 15, 2000
Human erythrocyte pyrimidine 5-nucleotidase, PN-I, is identical to p36, a protein associated to lupus inclusion formation in response to alpha-interferon
A Amici, M Emanuelli, N Raffaelli, et al.
Clinical Neuropharmacology
|
June 1, 1997
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease
S Ruggieri, M F De Pandis, A Bonamartini, et al.
Page
of 17